Global HPV Vaccine Market- By Region, By Country (2017-2022)

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022)

• By Region- North America, Europe,

APAC and RoW • By Country - United States, Canada, United Kingdom, Germany, France, China, India, Japan

• Company Analysis

(c) AZOTH Analytics

March 2018

Table of Content S.No

Particulars

Page No.

1.

Research Methodology

19

2.

Executive Summary

20

3.

Strategic Recommendation

21

3.1

Asia Pacific Region to witness fastest growth for HPV Treatment

22

3.2

Male segment is anticipated to witness highest growth

23

4.

HPV Vaccine Market: Product Outlook

24

5.

Global HPV Vaccine Market: Growth and Forecast

31

5.1

Global HPV Vaccine Market, By Value (2012-2016)

32

5.2

Global HPV Vaccine Market, By Value (2017-2022)

40

5.3

Global HPV Vaccine Market - By End-User, By Value

41

5.3.1

Global HPV Vaccine Market, By Value, % (2016)

41

5.3.2

Global HPV Vaccine Market, By Value, % (Forecast 2022F)

42

(c) AZOTH Analytics

2

Table of Content S.No

Particulars

5.4

5.5

6.

Page No.

Global HPV Vaccine Market, By End-User, By Value (2012-2022)

43

5.4.1

Male, By Value (2012-2022)

43

5.4.2

Female, By Value (2012-2022)

43

Global HPV Vaccine Market, By Age-Group, By Value (2012-2022)

44

5.5.1

Adolescent, By Value (2012-2022)

44

5.5.2

Adult, By Value (2012-2022)

44

North America HPV Vaccine Market: Growth and Forecast

46

6.1

North America HPV Vaccine Market, By Value (2012-2016)

47

6.2

North America HPV Vaccine Market, By Value (2017-2022)

50

6.3

North America HPV Vaccine Market - By End-User, By Value

51

6.3.1

North America HPV Vaccine Market, By Value, % (2016)

51

6.3.2

North America HPV Vaccine Market, By Value, % (Forecast 2022F)

52

6.4

North America HPV Vaccine Market, By End-User, By Value (2012-2022)

53

6.4.1

Male, By Value (2012-2022)

53

6.4.2

Female, By Value (2012-2022)

53

(c) AZOTH Analytics

3

Table of Content S. No

Particulars

6.5

6.6

6.7

6.8

6.9

6.10

North America HPV Vaccine Market, By Age-Group, By Value (2012-2022)

Page No.

54

6.5.1

Adolescent, By Value (2012-2022)

54

6.5.2

Adult, By Value (2012-2022)

54

North America HPV Vaccine Market: Country Analysis (U.S., Canada)

55

6.6.1

North America HPV Vaccine Market, Country Share, 2016 (% of Total)

55

6.6.2

North America HPV Vaccine Market, Country Share, 2022 (% of Total)

55

U.S. HPV Vaccine Market: Growth and Forecast

57

6.7.1

U.S. HPV Vaccine Market, By Value (2012-2016)

58

6.7.2

U.S. HPV Vaccine Market, By Value (2017-2022)

58

U.S. HPV Vaccine Market - By End-User, By Value

64

6.8.1

Male, By Value (2012-2022)

64

6.8.2

Female, By Value (2012-2022)

64

Canada HPV Vaccine Market: Growth and Forecast

66

6.9.1

Canada HPV Vaccine Market, By Value (2012-2016)

67

6.9.2

Canada HPV Vaccine Market, By Value (2017-2022)

67

Canada HPV Vaccine Market - By End-User, By Value

74

6.10.1

Male, By Value (2012-2022)

74

6.10.2

Female, By Value (2012-2022)

74

(c) AZOTH Analytics

4

Table of Content S.No

7.

Particulars

Europe HPV Vaccine Market: Growth and Forecast

Page No.

75

7.1

Europe HPV Vaccine Market, By Value (2012-2016)

76

7.2

Europe HPV Vaccine Market, By Value (2017-2022)

80

7.3

Europe HPV Vaccine Market - By End-User, By Value

81

7.3.1

Europe HPV Vaccine Market, By Value, % (2016)

81

7.3.2

Europe HPV Vaccine Market, By Value, % (Forecast 2022F)

82

7.4

7.5

7.6

Europe HPV Vaccine Market, By End-User, By Value (2012-2022)

83

7.4.1

Male, By Value (2012-2022)

83

7.4.2

Female, By Value (2012-2022)

83

Europe HPV Vaccine Market, By Age-Group, By Value (2012-2022)

84

7.5.1

Adolescent, By Value (2012-2022)

84

7.5.2

Adult, By Value (2012-2022)

84

Europe HPV Vaccine Market: Country Analysis (U.K., Germany, France & Rest of Europe)

85

7.6.1

Europe HPV Vaccine Market, Country Share, 2016 (% of Total)

85

7.6.2

Europe HPV Vaccine Market, Country Share, 2022 (% of Total)

85

(c) AZOTH Analytics

5

Table of Content S. No

Particulars

7.7

7.8

7.9

7.10

U.K. HPV Vaccine Market: Growth and Forecast

Page No.

88

7.7.1

U.K. HPV Vaccine Market, By Value (2012-2016)

89

7.7.2

U.K. HPV Vaccine Market, By Value (2017-2022)

89

U.K. HPV Vaccine Market - By End-User, By Value

94

7.8.1

Male, By Value (2012-2022)

94

7.8.2

Female, By Value (2012-2022)

94

Germany HPV Vaccine Market: Growth and Forecast

96

7.9.1

Germany HPV Vaccine Market, By Value (2012-2016)

97

7.9.2

Germany HPV Vaccine Market, By Value (2017-2022)

97

Germany HPV Vaccine Market - By End-User, By Value

104

7.10.1

Male, By Value (2012-2022)

104

7.10.2

Female, By Value (2012-2022)

104

(c) AZOTH Analytics

6

Table of Content S. No

Particulars

7.11

7.12

7.13

8.

Page No.

France HPV Vaccine Market: Growth and Forecast

105

7.11.1

France HPV Vaccine Market, By Value (2012-2016)

105

7.11.2

France HPV Vaccine Market, By Value (2017-2022)

106

France HPV Vaccine Market - By End-User, By Value

111

7.12.1

Male, By Value (2012-2022)

111

7.12.2

Female, By Value (2012-2022)

111

Rest of Europe HPV Vaccine Market: Growth and Forecast

112

7.13.1

Rest of Europe HPV Vaccine Market, By Value (2012-2016)

112

7.13.2

Rest of Europe Vaccine Market, By Value (2017-2022)

112

Asia-Pacific HPV Vaccine Market: Growth and Forecast

113

8.1

Asia-Pacific HPV Vaccine Market, By Value (2012-2016)

114

8.2

Asia-Pacific HPV Vaccine Market, By Value (2017-2022)

120

8.3

Asia-Pacific HPV Vaccine Market - By End-User, By Value

121

8.3.1

Asia-Pacific HPV Vaccine Market, By Value, % (2016)

121

8.3.2

Asia-Pacific HPV Vaccine Market, By Value, % (Forecast 2022F)

122

(c) AZOTH Analytics

7

Table of Content S.No

Particulars

8.4

8.5

8.6

8.7

8.8

Page No.

Asia-Pacific HPV Vaccine Market, By End-User, By Value (2012-2022)

123

8.4.1

Male, By Value (2012-2022)

123

8.4.2

Female, By Value (2012-2022)

123

Asia-Pacific HPV Vaccine Market, By Age-Group, By Value (2012-2022)

124

8.5.1

Adolescent, By Value (2012-2022)

124

8.5.2

Adult, By Value (2012-2022)

124

Asia-Pacific HPV Vaccine Market: Country Analysis (Japan, China, India)

125

8.6.1

Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)

125

8.6.2

Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)

125

Japan HPV Vaccine Market: Growth and Forecast

127

8.7.1

Japan HPV Vaccine Market, By Value (2012-2016)

128

8.7.2

Japan HPV Vaccine Market, By Value (2017-2022)

128

Japan HPV Vaccine Market - By End-User, By Value 8.8.1

Male, By Value (2012-2022)

8.8.2

Female, By Value (2012-2022)

131 11

131

(c) AZOTH Analytics

8

Table of Content S. No

Particulars

8.9

8.10

8.11

8.12

9.

China HPV Vaccine Market: Growth and Forecast

Page No.

132

8.9.1

China HPV Vaccine Market, By Value (2012-2016)

133

8.9.2

China HPV Vaccine Market, By Value (2017-2022)

133

China HPV Vaccine Market - By End-User, By Value

139

8.10.1

Male, By Value (2012-2022)

139

8.10.2

Female, By Value (2012-2022)

139

India HPV Vaccine Market: Growth and Forecast

140

8.11.1

India HPV Vaccine Market, By Value (2012-2016)

141

8.11.2

India HPV Vaccine Market, By Value (2017-2022)

141

India HPV Vaccine Market - By End-User, By Value

147

8.12.1

Male, By Value (2012-2022)

147

8.12.2

Female, By Value (2012-2022)

147

ROW HPV Vaccine Market: Growth and Forecast

148

9.1

ROW HPV Vaccine Market, By Value (2012-2016)

149

9.2

ROW HPV Vaccine Market, By Value (2017-2022)

150

(c) AZOTH Analytics

9

Table of Content S. No

10.

Particulars

Market Dynamics

Page No.

153

10.1

Increasing healthcare awareness about Sexually Transmissible Disease

155

10.2

Development of Healthcare Infrastructure

156

10.3

Rising global healthcare expenditure and favorable reimbursed policies

157

11.

Market Restraints

158

12.

Market Trends

160

13.

SWOT Analysis – HPV Vaccine Market

163

14.

Porter’s Five Forces Analysis

165

15.

Policy and Regulatory Landscape

167

16.

Company Profile

177

17.

16.1

Merck and Co

16.2

GlaxoSmithKline

178 181

About Us

184

(c) AZOTH Analytics

10

List of Figures Figure No.

Figure Title

Page No.

Figure 1:

Global HPV vaccine Market Size, By Value, 2012-2016 (USD Million)

32

Figure 2:

World Male Population Estimates, 2017 (In Millions)

33

Figure 3:

World Female Population Estimates, 2017 (In Millions)

33

Figure 4:

World Female Population, Age 10-14 Years Old (2012-2016)

34

Figure 5:

World Male Population, Age 10-14 Years Old (2012-2016)

34

Figure 6:

Global Healthcare Expenditure, 2012-2016 (In Trillion)

36

Figure 7:

Top 10 Most Frequent Cancer in Females, World, (Age−standardised incidence rate per 100,000 women)

37

Figure 8:

Top 10 Most Frequent Cancer Deaths in Females, World, (Age−standardised incidence rate per 100,000 women)

37

Figure 9:

Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region

37

Figure 10:

HPV Related Cancer Cases in Women/ Year, 530,000

38

Figure 11:

HPV Related Cancer Cases in Men/ Year, 39,000

38

Figure 12:

Global HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)

40

Figure 13:

Global HPV vaccine Market Size, By End-User, 2016 (%)

41

Figure 14:

Global HPV Vaccine Market Size, By End-User, 2022 (%)

42

Figure 15:

Global HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)

43

Figure 16:

Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)

44

Figure 17:

North America HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)

47

Figure 18:

North America GDP, 2012-2015 (USD Trillion)

48

Figure 19:

North America GDP, By Select Country, 2016 (USD Trillion)

48

(c) AZOTH Analytics

11

List of Figures Figure No.

Figure Title

Page No.

Figure 20:

North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)

48

Figure 21:

North America Female Population, Age 10-14 Years Old (2012-2016)

49

Figure 22:

North America Male Population, Age 10-14 Years Old (2012-2016)

49

Figure 23:

North America HPV Vaccine Market Size, By Value, 2017-2022(USD Million)

50

Figure 24:

North America HPV vaccine Market Size, By End-User , 2016 (%)

51

Figure 25:

North America HPV Vaccine Market Size, By End-User, 2022 (%)

52

Figure 26:

North America HPV Vaccine Market, End-User, By Value 2012-2022 (USD Million)

53

Figure 27:

North America HPV Vaccine Market, By Age Group, By Value 2012-2022 (USD Million)

54

Figure 28:

North America HPV Vaccine Market, Country Share, 2016 (% of Total)

55

Figure 29:

North America HPV Vaccine Market, Country Share, 2022 (% of Total)

55

Figure 30:

U.S. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

58

Figure 31:

U.S. Female Population, Age 10-14 Years Old (2012-2016)

61

Figure 32:

U.S. Male Population, Age 10-14 Years Old (2012-2016)

61

Figure 33:

U.S. Per Capita Healthcare Expenditure, 2012-2016 (In USD)

61

Figure 34:

U.S. HPV vaccine Market Size, By End-User, 2016 (%)

62

Figure 35:

U.S. HPV Vaccine Market Size, By End-User, 2022 (%)

63

Figure 36:

U.S. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)

64

Figure 37:

Annual Sales of Cervarix vaccines in U.S., (In Million USD) 2012-2016

65

Figure 38:

Canada HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

67

Figure 39:

Canada Female Population, Age 10-14 Years Old (2012-2016)

68

(c) AZOTH Analytics

12

List of Figures Figure No.

Figure Title

Page No.

Figure 40:

Canada Male Population, Age 10-14 Years Old (2012-2016)

68

Figure 41:

Normal Cytology

70

Figure 42:

Low-Grade lesions

70

Figure 43:

High-Grade lesions

70

Figure 44:

Cervical Cancer

70

Figure 45:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

71

Figure 46:

Canada HPV vaccine Market Size, By End-User, 2016 (%)

72

Figure 47:

Canada HPV Vaccine Market Size, By End-User, 2022 (%)

73

Figure 48:

Canada HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)

74

Figure 49:

Europe HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)

76

Figure 50:

Europe, Female Population aged 15+, By Region, 2017 (In Millions)

77

Figure 51:

European Union, Per Capita Healthcare Expenditure, 2012-2014 (In USD)

77

Figure 52:

Europe Female Population, Age 10-14 Years Old (2012-2016)

77

Figure 53:

Europe Male Population, Age 10-14 Years Old (2012-2016)

77

Figure 54:

Europe, GDP, By Select Country, 2016 (USD Billion)

78

Figure 55:

Europe Health Spending Per Capita, By Select Country, 2016 (USD)

78

Figure 56:

Europe HPV Vaccine Market Size, By Value, Forecast, 2017-2022 (USD Million)

80

Figure 57:

Europe HPV Vaccine Market Size, By End-User, 2016 (%)

81

Figure 58:

Europe HPV Vaccine Market Size, By End-User, 2022 (%)

82

Figure 59:

Europe HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)

83

Figure 60:

Europe HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)

84

(c) AZOTH Analytics

13

List of Figures Figure No.

Figure Title

Page No.

Figure 61:

Europe HPV Vaccine Market, Country Share, 2016 (% of Total)

85

Figure 62:

Europe HPV Vaccine Market, Country Share, 2022 (% of Total)

85

Figure 63:

Annual Sales of Cervarix vaccines in Europe, (In Million USD) 2012-2016

86

Figure 64:

U.K. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

89

Figure 65:

U.K. Female Population, Age 10-14 Years Old (2012-2016)

91

Figure 66:

U.K. Male Population, Age 10-14 Years Old (2012-2016)

91

Figure 67:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

91

Figure 68:

U.K., Per Capita Healthcare Expenditure, 2012-2016 (In USD)

91

Figure 69:

U.K. HPV Vaccine Market Size, By End User, 2016 (%)

92

Figure 70:

U.K. HPV Vaccine Market Size, By End User, 2022 (%)

93

Figure 71:

U.K. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)

94

Figure 72:

Germany HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

97

Figure 73:

Germany Female Population, Age 10-14 Years Old (2012-2016)

98

Figure 74:

Germany Male Population, Age 10-14 Years Old (2012-2016)

98

Figure 75:

Germany Per Capita Healthcare Expenditure, 2012 - 2014 (In USD)

98

Figure 76:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

99

Figure 77:

Germany HPV Vaccine Market Size, By End User, 2016 (%)

102

Figure 78:

Germany HPV Vaccine Market Size, By End User, 2022 (%)

103

Figure 79:

Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)

104

Figure 80:

France HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

106

(c) AZOTH Analytics

14

List of Figures Figure No.

Figure Title

Page No.

Figure 81:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

107

Figure 82:

France Female Population, Age 10-14 Years Old (2012-2016)

108

Figure 83:

France Male Population, Age 10-14 Years Old (2012-2016)

108

Figure 84:

France Per Capita Healthcare Expenditure, 2012-2014 (In USD)

108

Figure 85:

France HPV Vaccine Market Size, By End-User, 2016 (%)

109

Figure 86:

France HPV Vaccine Market Size, By End-User, 2022 (%)

110

Figure 87:

France HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)

111

Figure 88:

Rest of Europe HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

112

Figure 89:

Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)

114

Figure 90:

Asia Female Population, Age 10-14 Years Old (2012-2016)

118

Figure 91:

Asia Male Population, Age 10-14 Years Old (2012-2016)

118

Figure 92:

APAC, GDP, By Select Country, 2016 (USD Billion)

119

Figure 93:

APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)

119

Figure 94:

Asia-Pacific HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)

120

Figure 95:

Asia-Pacific HPV Vaccine Market Size, By End-User, 2016 (%)

121

Figure 96:

Asia-Pacific HPV Vaccine Market Size, By End-User, 2022 (%)

122

Figure 97:

Asia-pacific HPV Vaccine - End-User, By Value 2012-2022 (USD Million)

123

Figure 98:

Asia-Pacific HPV Vaccine Market – Age Group, By Value 2012-2022 (USD Million)

124

Figure 99:

Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)

125

Figure 100:

Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)

125

(c) AZOTH Analytics

15

List of Figures Figure No.

Figure Title

Page No.

Figure 101:

Japan HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

128

Figure 102:

Japan HPV Vaccine Market Size, By End-User, 2016 (%)

129

Figure 103:

Japan HPV Vaccine Market Size, By End-User, 2022 (%)

130

Figure 104:

Japan HPV Vaccine - End-User, By Value 2012-2022 (USD Million)

131

Figure 105:

China HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

133

Figure 106:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

135

Figure 107:

China Female Population, Age 10-14 Years Old (2012-2016)

136

Figure 108:

China Male Population, Age 10-14 Years Old (2012-2016)

136

Figure 109:

China Per Capita Healthcare Expenditure, 2012-2014 (In USD)

136

Figure 110:

China HPV Vaccine Market Size, By End-User, 2016 (%)

137

Figure 111:

China HPV Vaccine Market Size, By End-User, 2022 (%)

138

Figure 112:

China HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)

139

Figure 113:

India HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

141

Figure 114:

India Female Population, Age 10-14 Years Old (2012-2016)

143

Figure 115:

India Male Population, Age 10-14 Years Old (2012-2016)

143

Figure 116:

Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)

143

Figure 117:

India HPV Vaccine Market Size, By End-User, 2016 (%)

144

Figure 118:

India HPV Vaccine Market Size, By End-User, 2022 (%)

145

Figure 119:

India HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)

146

Figure 120:

Rest of Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)

147

(c) AZOTH Analytics

16

List of Figures Figure No.

Figure Title

Page No.

Figure 121:

ROW HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)

149

Figure 122:

ROW HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)

150

Figure 123:

Africa Female Population, Age 10-14 Years Old (2012-2016)

151

Figure 124:

Africa Male Population, Age 10-14 Years Old (2012-2016)

151

Figure 125:

Prevalence of Cervical Cancer, among women in Africa (Patients per 100,000 (2012-2016)

151

Figure 126:

Prevalence of Cervical Cancer among female in Brazil (Patients per 100,000 (2012-2016)

152

Figure 127:

Global Healthcare Expenditure, 2012-2016 (In Trillion)

157

Figure 128:

Annual Sales of HPV vaccines, By leading players, (In Million USD) 2012-2016

175

Figure 129:

Market Share of Leading players in HPV vaccine market, 2016

176

Figure 130:

Merck & Co., Net Sales, 2012-2016 (In million USD)

179

Figure 131:

Merck & Co, Net Sales of Gardasil/Gardasil 9, 2012-2016 (In million USD)

179

Figure 132:

Merck & Co., Net Sales, By Geographic Location, % Share 2016

179

Figure 133:

Merck & Co., Net Revenue, By Business Segment, % Share 2016

179

Figure 134:

GlaxoSmithKline Annual Revenue, 2014-2016 (USD Million)

182

Figure 135:

Sales from Hepatitis Vaccination, GlaxoSmithKline, 2015 - 2016 (USD Million)

182

Figure 136:

GlaxoSmithKline Sales, By Region, 2016 (%)

182

Figure 137:

GlaxoSmithKline, Sales, By Segment 2016 (%)

182

(c) AZOTH Analytics

17

List of Tables Table No.

Table A:

Table B:

Table C:

Table D:

Table E:

Table F:

Table G:

Table H:

Table I:

Table Title

Globally approved HPV vaccines, 2016

Page No.

29

HPV Vaccine Market Segmentation Flowchart

30

Estimated number of HPV Associated cases in 2017

Estimated new HPV related cancers cases, 2011, 2012 & 2016 Newly registered diagnosed cases of HPV related cancer in England, 2016

Estimated and Predicted HPV related cancer among male and female, 2011, 2012 & 2016

Estimated and Predicted HPV related cancer among female, 2011, 2012 & 2016

Key Statistics on HPV burden in Asia

59

69

90

100

100

114

Estimated HPV related New Cancer Cases and Deaths (Thousands), By Sex, 2015

(c) AZOTH Analytics

135

18

Research Methodology For our study on Global HPV Vaccine Market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of HPV Vaccine Market.

Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other end-user sectors.

Market sizing and growth in the forecast period (2017-2022) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: HPV Vaccine Market -By Region- North America, Europe, APAC and ROW -By Country - United States, Canada, United Kingdom, Germany, France, China, India, Japan Company Analysis

Companies Contacted: GlaxoSmithKline Pharmaceuticals Ltd

(c) AZOTH Analytics

19

Global HPV Vaccine Market Overview Rising Prevalence of Sexually Transmissible Diseases, increasing global adolescence population, growing healthcare burden due to Sexually Transmissible virus propelled the market growth Figure : Global HPV vaccine Market Size, By Value, 2012-2016 (USD Million) CAGR 2012-2016 HPV: xx%;

2012

2013

2014 Source: Azoth Analytics Estimates

2015

2016

Xxxxx

Xxxxx Xxxxx Xxxxx Xxxxx xxxxx

(c) AZOTH Analytics

20

Global HPV Vaccine Market - By Age Group, By Value Figure : Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)

2012

CAGR 2012-2016

CAGR 2017-2022

Adolescent: xx%; Adult: xx%

Adolescent: xx%; Adult: xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

Source: Azoth Analytics Estimates Xxxxx Xxxxx Xxxxx

Xxxxx Xxxxx xxxxx

(c) AZOTH Analytics

21

North America HPV Vaccine Market - By End-User, By Value Higher healthcare burden due to Cervical Cancer caused by HPV virus is attributed to the larger market share in female segment

Figure : North America HPV vaccine Market Size, By

Key Drivers

End-User , 2016 (%)

Xxxxx xxxxx Male

Xxxxx xxxxx

Xxxxx Female

xxxxx

Xxxxx xxxxx Source: Azoth Analytics Estimates

(c) AZOTH Analytics

22

Germany HPV Vaccine Market - By End-User, By Value Figure : Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)

2012

CAGR 2012-2016

CAGR 2017-2022

Male: xx%; Female: xx%

Male: xx%; Female: xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

Source: Azoth Analytics Estimates Xxxxx Xxxxx Xxxxx Xxxxx xxxxx

(c) AZOTH Analytics

23

Asia-Pacific HPV Vaccine Market - By Country Share

Figure : Asia-Pacific HPV Vaccine Market, Country

Figure : Asia-Pacific HPV Vaccine Market, Country

Share, 2016 (% of Total)

Share, 2022 (% of Total)

Source: Azoth Analytics Estimates

Japan

Japan

China

China

India

India

Others

Others

Source: Azoth Analytics Estimates

(c) AZOTH Analytics

24

About Azoth Analytics Pvt Ltd. Azoth Analytics is a business research and analytics firm that creates in-depth research res and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and Pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research res by recording, interpreting and analyzing information. Strategic market sizing and data dredging End Users include secondary research, and primary research (interviews with management personnel and industry experts).

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or User.. Also, analysis provided in the re are meant for customers’ internal use only and not for general publication or disclosure to third parties.

(c) AZOTH Analytics

25